These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Failure of cyprohepatdine to inhibit vasopressin-stimulated cortisol release in a patient with Cushing's disease. George WF; Husain M; Lock JP; Katz FH Horm Res; 1976; 7(4-5):308-12. PubMed ID: 1017793 [TBL] [Abstract][Full Text] [Related]
65. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease. Lankford HV; Tucker HS; Blackard WG N Engl J Med; 1981 Nov; 305(21):1244-8. PubMed ID: 6270557 [TBL] [Abstract][Full Text] [Related]
66. Drugs in the medical treatment of Cushing's syndrome. Schteingart DE Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210 [TBL] [Abstract][Full Text] [Related]
67. Bromocriptine-responsive Cushing's disease associated with anterior pituitary corticotroph hyperplasia or normal pituitary gland. Croughs RJ; Koppeschaar HP; van't Verlaat JW; McNicol AM J Clin Endocrinol Metab; 1989 Feb; 68(2):495-8. PubMed ID: 2537335 [TBL] [Abstract][Full Text] [Related]
69. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease. Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123 [TBL] [Abstract][Full Text] [Related]
70. Cushing's disease: megadose dexamethasone suppression in a case refractory to medical therapy. Warren SE; Westbie DK; Daly R; Bower RH South Med J; 1979 Apr; 72(4):412-4. PubMed ID: 219547 [TBL] [Abstract][Full Text] [Related]
71. [Criteria for the selection of drugs for the pathogenetic treatment of Itsenko-Cushing disease]. Slavnov VN; Luchitskiĭ EV; Cheban AK Ter Arkh; 1985; 57(12):36-9. PubMed ID: 3003946 [TBL] [Abstract][Full Text] [Related]
72. [Drug and radiotherapy of pituitary tumors]. Yoshida H; Takeda F; Kinouchi T; Shimizu N Nihon Rinsho; 1986 Mar; 44(3):659-66. PubMed ID: 3016373 [No Abstract] [Full Text] [Related]
79. [Changes in the secretion of the hormones of the hypothalamo-hypophyseo-adrenal system in Itsenko-Cushing disease under the influence of insulin-induced hypoglycemia and thyroliberin]. Slavnov VN; Luchitskiĭ EV Vrach Delo; 1990 Mar; (3):72-5. PubMed ID: 2164280 [TBL] [Abstract][Full Text] [Related]
80. Personality characteristics and quality of life in patients treated for Cushing's syndrome. Sonino N; Bonnini S; Fallo F; Boscaro M; Fava GA Clin Endocrinol (Oxf); 2006 Mar; 64(3):314-8. PubMed ID: 16487442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]